Skip to main content
Top
Published in: BMC Infectious Diseases 1/2023

Open Access 01-12-2023 | Intracranial Hypertension | Case Report

Persistent neurological symptoms and elevated intracranial pressures in a previously healthy host with cryptococcal meningitis

Authors: Mohammad El-Atoum, Jessica C. Hargarten, Yoon-Dong Park, Kenneth Ssebambulidde, Li Ding, Prashant Chittiboina, Dima A. Hammoud, Seher H. Anjum, Seth R. Glassman, Shehzad Merchant, Peter R. Williamson, John C. Hu

Published in: BMC Infectious Diseases | Issue 1/2023

Login to get access

Abstract

Cryptococcal meningoencephalitis can occur in both previously healthy and immunocompromised hosts. Here, we describe a 55 year-old HIV-negative male with no known prior medical problems, who presented with three months of worsening headaches, confusion, and memory changes without fever. Magnetic resonance imaging of the brain demonstrated bilateral enlargement/enhancement of the choroid plexi, with hydrocephalus, temporal and occipital horn entrapments, as well as marked periventricular transependymal cerebrospinal fluid (CSF) seepage. CSF analysis yielded a lymphocytic pleocytosis and cryptococcal antigen titer of 1:160 but sterile fungal cultures. Despite standard antifungal therapy and CSF drainage, the patient had worsening confusion and persistently elevated intracranial pressures. External ventricular drainage led to improved mental status but only with valve settings at negative values. Ventriculoperitoneal shunt placement could thus not be considered due to a requirement for drainage into the positive pressure venous system. Due to this persistent CSF inflammation and cerebral circulation obstruction, the patient required transfer to the National Institute of Health. He was treated for cryptococcal post-infectious inflammatory response syndrome with pulse-taper corticosteroid therapy, with resultant reductions in CSF pressures along with decreased protein and obstructive material, allowing successful shunt placement. After tapering of corticosteroids, the patient recovered without sequelae. This case highlights (1) the necessity to consider cryptococcal meningitis as a rare cause of neurological deterioration in the absence of fever even in apparently immunocompetent individuals and (2) the potential for obstructive phenomena from inflammatory sequelae and the prompt response to corticosteroid therapy.
Literature
2.
go back to reference Bennett JE, Dolin R, Blaser MJ. Mandell, Douglas, and Bennett’s principles and practice of infectious diseases. Eighth edition. ed. 2 volumes p. Bennett JE, Dolin R, Blaser MJ. Mandell, Douglas, and Bennett’s principles and practice of infectious diseases. Eighth edition. ed. 2 volumes p.
7.
go back to reference Pappas PG, Perfect JR, Cloud GA, Larsen RA, Pankey GA, Lancaster DJ, et al. Cryptococcosis in human immunodeficiency virus-negative patients in the era of effective azole therapy. Clin Infect diseases: official publication Infect Dis Soc Am. 2001;33(5):690–9. 10.1086/322597. PubMed PMID: 11477526.CrossRef Pappas PG, Perfect JR, Cloud GA, Larsen RA, Pankey GA, Lancaster DJ, et al. Cryptococcosis in human immunodeficiency virus-negative patients in the era of effective azole therapy. Clin Infect diseases: official publication Infect Dis Soc Am. 2001;33(5):690–9. 10.1086/322597. PubMed PMID: 11477526.CrossRef
9.
go back to reference Hirsch HH, Kaufmann G, Sendi P, Battegay M. Immune reconstitution in HIV-infected patients. Clin Infect diseases: official publication Infect Dis Soc Am. 2004;38(8):1159–66. 10.1086/383034. PubMed PMID: 15095223.CrossRef Hirsch HH, Kaufmann G, Sendi P, Battegay M. Immune reconstitution in HIV-infected patients. Clin Infect diseases: official publication Infect Dis Soc Am. 2004;38(8):1159–66. 10.1086/383034. PubMed PMID: 15095223.CrossRef
10.
go back to reference Neal LM, Xing E, Xu J, Kolbe JL, Osterholzer JJ, Segal BM, et al. CD4(+) T cells orchestrate Lethal Immune Pathology despite Fungal Clearance during Cryptococcus neoformans Meningoencephalitis. mBio. 2017;8(6). https://doi.org/10.1128/mBio.01415-17. PubMed PMID: 29162707; PubMed Central PMCID: PMC5698549. Neal LM, Xing E, Xu J, Kolbe JL, Osterholzer JJ, Segal BM, et al. CD4(+) T cells orchestrate Lethal Immune Pathology despite Fungal Clearance during Cryptococcus neoformans Meningoencephalitis. mBio. 2017;8(6). https://​doi.​org/​10.​1128/​mBio.​01415-17. PubMed PMID: 29162707; PubMed Central PMCID: PMC5698549.
11.
go back to reference Anjum S, Dean O, Kosa P, Magone MT, King KA, Fitzgibbon E, et al. Outcomes in previously healthy cryptococcal meningoencephalitis patients treated with pulse taper corticosteroids for post-infectious inflammatory syndrome. Clin Infect diseases: official publication Infect Dis Soc Am. 2021;73(9):e2789–e98. https://doi.org/10.1093/cid/ciaa1901. PubMed PMID: 33383587; PubMed Central PMCID: PMC8563180.CrossRef Anjum S, Dean O, Kosa P, Magone MT, King KA, Fitzgibbon E, et al. Outcomes in previously healthy cryptococcal meningoencephalitis patients treated with pulse taper corticosteroids for post-infectious inflammatory syndrome. Clin Infect diseases: official publication Infect Dis Soc Am. 2021;73(9):e2789–e98. https://​doi.​org/​10.​1093/​cid/​ciaa1901. PubMed PMID: 33383587; PubMed Central PMCID: PMC8563180.CrossRef
15.
go back to reference Perfect JR, Casadevall A, Cryptococcosis. Infectious disease clinics of North America. 2002;16(4):837 – 74, v-vi. doi: 10.1016/s0891-5520(02)00036-3. PubMed PMID: 12512184. Perfect JR, Casadevall A, Cryptococcosis. Infectious disease clinics of North America. 2002;16(4):837 – 74, v-vi. doi: 10.1016/s0891-5520(02)00036-3. PubMed PMID: 12512184.
19.
go back to reference Cherian J, Atmar RL, Gopinath SP. Shunting in cryptococcal meningitis. Journal of neurosurgery. 2016;125(1):177 – 86. doi: 10.3171/2015.4.JNS15255. PubMed PMID: 26517766. Cherian J, Atmar RL, Gopinath SP. Shunting in cryptococcal meningitis. Journal of neurosurgery. 2016;125(1):177 – 86. doi: 10.3171/2015.4.JNS15255. PubMed PMID: 26517766.
20.
go back to reference Kamat AS, Gretschel A, Vlok AJ, Solomons R. CSF protein concentration associated with ventriculoperitoneal shunt obstruction in tuberculous meningitis. Int J tuberculosis lung disease: official J Int Union against Tuberculosis Lung Disease. 2018;22(7):788–92. https://doi.org/10.5588/ijtld.17.0008. PubMed PMID: 29914605.CrossRef Kamat AS, Gretschel A, Vlok AJ, Solomons R. CSF protein concentration associated with ventriculoperitoneal shunt obstruction in tuberculous meningitis. Int J tuberculosis lung disease: official J Int Union against Tuberculosis Lung Disease. 2018;22(7):788–92. https://​doi.​org/​10.​5588/​ijtld.​17.​0008. PubMed PMID: 29914605.CrossRef
21.
go back to reference Mehta GU, Panackal AA, Murayi R, Bennett JE, Williamson PR, Chittiboina P. Corticosteroids for shunted previously healthy patients with non-HIV cryptococcal meningoencephalitis. Journal of neurology, neurosurgery, and psychiatry. 2018;89(2):219–20. doi: https://doi.org/10.1136/jnnp-2017-315830. PubMed PMID: 28550070; PubMed Central PMCID: PMC5702587. Mehta GU, Panackal AA, Murayi R, Bennett JE, Williamson PR, Chittiboina P. Corticosteroids for shunted previously healthy patients with non-HIV cryptococcal meningoencephalitis. Journal of neurology, neurosurgery, and psychiatry. 2018;89(2):219–20. doi: https://​doi.​org/​10.​1136/​jnnp-2017-315830. PubMed PMID: 28550070; PubMed Central PMCID: PMC5702587.
23.
24.
25.
go back to reference Kuo PH, Wu UI, Pan YH, Wang JT, Wang YC, Sun HY, et al. Neutralizing anti-granulocyte-macrophage colony-stimulating factor autoantibodies in patients with Central Nervous System and localized cryptococcosis: Longitudinal Follow-up and Literature Review. Clin Infect diseases: official publication Infect Dis Soc Am. 2022;75(2):278–87. https://doi.org/10.1093/cid/ciab920. PubMed PMID: 34718451.CrossRef Kuo PH, Wu UI, Pan YH, Wang JT, Wang YC, Sun HY, et al. Neutralizing anti-granulocyte-macrophage colony-stimulating factor autoantibodies in patients with Central Nervous System and localized cryptococcosis: Longitudinal Follow-up and Literature Review. Clin Infect diseases: official publication Infect Dis Soc Am. 2022;75(2):278–87. https://​doi.​org/​10.​1093/​cid/​ciab920. PubMed PMID: 34718451.CrossRef
Metadata
Title
Persistent neurological symptoms and elevated intracranial pressures in a previously healthy host with cryptococcal meningitis
Authors
Mohammad El-Atoum
Jessica C. Hargarten
Yoon-Dong Park
Kenneth Ssebambulidde
Li Ding
Prashant Chittiboina
Dima A. Hammoud
Seher H. Anjum
Seth R. Glassman
Shehzad Merchant
Peter R. Williamson
John C. Hu
Publication date
01-12-2023
Publisher
BioMed Central
Published in
BMC Infectious Diseases / Issue 1/2023
Electronic ISSN: 1471-2334
DOI
https://doi.org/10.1186/s12879-023-08349-y

Other articles of this Issue 1/2023

BMC Infectious Diseases 1/2023 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine